Global Radiotherapy, Radiopharmaceuticals and Nuclear Medicine Markets report 2019 Featuring Profiles of Accuray, Bayer, C. R. Bard., Eli Lilly and Co, Navidea, Siemens, and Triad Isotopes

News provided by

May 30, 2019, 18:00 ET

DUBLIN, May 30, 2019 /PRNewswire/ -- The "Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets" report has been added to ResearchAndMarkets.com's offering.

Population and human life expectancy are growing globally, spurring more chronic conditions and life-threatening diseases. Obesity, a sedentary lifestyle and a lack of physical activity have further worsened the situation, leading to the increased importance of medical interventions and treatments. Despite incredible advancements in the field of medicine in the last few decades, an unmet need remains for the prevention, diagnosis and treatment of aggressive ailments such as cancer, cardiovascular diseases and central nervous system disorders.

Since the discovery of radioactivity, it has been recognized that radiation can play a role in the treatment of various diseases. Radiopharmaceuticals are a type of radioactive drug that is internally administered and intended for use in the diagnosis and treatment of diseases. Radiopharmaceuticals are now a crucial part of the healthcare industry, as they can identify various disease processes much earlier than other diagnostic tests.

Applications of radiopharmaceuticals are growing significantly in the fields of cardiology, neurology, oncology and other medical specialties such as endocrinology, gastroenterology and nephrology, for both diagnostic and therapeutic purposes. Radiopharmaceuticals have also become an inevitable part of personalized medicine. The market for therapeutic radiopharmaceuticals is expected to grow at a steep rate in the coming years, due to growing applications and increased demand.

Growing acceptance and utilization of nuclear medicine scans (i.e., SPECT and PET) and better availability of radiopharmaceuticals due to an increasing number of cyclotrons have significantly contributed to growth in the radiopharmaceutical industry. Innovative technological equipment leading to early and accurate diagnoses, increased awareness of radiopharmaceuticals among physicians and patients and new regulatory approvals of radiopharmaceuticals are other major driving forces for the global radiopharmaceutical market. Furthermore, increasing incidences of different types of cancers across the globe are considered a major driver behind the growth of radiopharmaceuticals and therapeutics.

The Report Includes:

94 data tables and 83 additional tables
An overview of the global market for radiotherapy, radiopharmaceuticals and nuclear medicines
Examination of present and future strategies within the radiopharmaceuticals market, including radiopharmaceuticals for both diagnostic and therapeutic purposes
Detailed description of positron emission tomography (PET) and single photon emission computed tomography (SPECT) and discussion of their applications
Evaluation of market opportunities for external beam radiation therapy, internal radiation therapy and systemic radiotherapy
Coverage of new products launches and product enhancement in the industry
Comprehensive company profiles of major players, including Accuray Inc., Bayer Pharma AG, C. R. Bard Inc., Eli Lilly and Company, Navidea Biopharmaceuticals Inc., Siemens Healthcare, and Triad Isotopes Inc.

Key Topics Covered:

Chapter 1 Introduction

Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
Custom Research
Related Reports

Chapter 2 Executive Summary

Chapter 3 Market Overview

Introduction: Radiopharmaceuticals
Uses of Radiopharmaceuticals
Evolution and Transition: Radiopharmaceuticals
Introduction: Radiotherapy
Ionizing Radiation
Non-ionizing Radiation
Evolution and Transition: Radiation Therapy
The Discovery Period: 1890s
Kilovoltage Era: 1900 to 1940
Megavoltage Era: 1946 to 1996
Computer-Assisted Era: 1996 to the Present
Market Potential
Regulatory Outlook
United States
Canada
Australia
India
European Union
Investment Analysis
Market Share Analysis
Segmentation Overview
Segmentation by Type: Radiotherapy
Segmentation by Type: Radiopharmaceuticals
Segmentation by Production Method
Segmentation by Technology
Radiopharmaceutical and Therapeutics Market, by Application
Geographic Overview
North America
Europe
Asia-Pacific
RoW

Chapter 4 Market Dynamics

Trends
Respiratory Gating
Proton Therapy
Carbon Ions
Magnetic Resonance-Driven Linear Accelerator
Drivers
Increasing Aging Population
Increasing Incidence of Life-Threatening Diseases
Increasing Incidences of Cancer
High Incidence of Cancer in Aging Population
Growing Healthcare Spending in Emerging Regions
Advancements in Technology
Growing Focus on Early Diagnosis and Treatment
Launch of New Radiopharmaceuticals and Widening Applications
Increasing Number of Cyclotrons
Increasing Amount of Nuclear Imaging Equipment
High Efficiency of Radiotherapy
Palliative Radiation Therapy
Government Funding
Reimbursement Boosting Market Growth
Restraints and Challenges
Limited Global Supply of Medical Isotopes
Reimbursement Policies
Healthcare Reforms and Budgetary Constraints in Developed Countries
Regulatory Issues
Expensive Equipment
Lack of Trained Professionals
Limited Effectiveness against Metastatic Cancer
Side Effects of Radiation Therapy
Therapeutic Bottlenecks
Opportunities
Developing Countries
Personalized Treatment
Replacement of Old Equipment

Chapter 5 Global Radiopharmaceutical and Therapeutics Market by Type

Radiotherapy
External Beam Radiation Therapy
Internal Radiation Therapy
Systemic Radiotherapy
Radiopharmaceuticals
Diagnostics
Therapeutics

Chapter 6 Global Radiopharmaceutical and Therapeutics Market by Production Method

Particle Accelerators (Cyclotrons)
Working of Particle Accelerators
Nuclear Reactors
Radionuclide Generators
Production of Radioisotopes through Radionuclides

Chapter 7 Global Radiopharmaceutical and Therapeutics Market by Technology

External Radiotherapy Market by Technology
Particle Therapy/Proton Beam Therapy
Stereotactic Radiosurgery (SRS) and Fractionated Stereotactic Radiation Therapy
Image-Guided Radiation Therapy (IGRT)
Intensity-Modulated Radiation Therapy (IMRT)
Tomotherapy
Three-Dimensional Conformal Radiation Therapy (3D-CRT)
Volumetric Modulated Arc Therapy (VMAT)
Internal Radiotherapy by Technology
Pulsed-Dose-Rate (PDR) Brachytherapy
Low-Dose-Rate Brachytherapy
High-Dose-Rate (HDR) Brachytherapy
Systemic Radiotherapy by Technology
Comparison between Alpha and Beta Emitters

Chapter 8 Global Radiopharmaceutical and Therapeutics Market by Application

External Beam Radiation Therapy
Treatment Planning for External Beam Radiation
Dosing and Treatment with External Beam Radiation
Electron-Emitting High-Energy Linear Accelerators (LINACS)
Internal Radiation Therapy
Applications of Internal Beam Radiation Therapy
Systemic Radiation Therapy
Applications of Systemic Radiation Therapy

Chapter 9 Geographic Analysis

North America
United States
Canada
Europe
United Kingdom
France
Germany
Spain
Rest of Europe
Asia-Pacific
China
India
Japan
Australia
Rest of Asia-Pacific
Rest of World (ROW)
Latin America
Middle East and Africa

Chapter 10 Industry Structure

Raw Material Procurement
Quality
Terms and Conditions
Cost-Effective Components
Manufacturing/Development Process
Distributors
End Users

Chapter 11 New Development and Current Situation

Pipeline Products
Current Market Scenario
Current Developments in Radiopharmaceuticals and Therapies

Chapter 12 Patent Analysis

U.S. Patent Analysis
European Patent Analysis
Japanese Patent Analysis

Chapter 13 Competitive Landscape

Product Launches
Collaborations, Agreements and Partnerships
Mergers and Acquisitions

Chapter 14 Company Profiles

Accuray Inc.
Actinium Pharmaceuticals Inc.
Advanced Accelerator Applications Sa (Novartis Co.)
Advanced Medical Isotope Corp. (Now Vivos Inc.)
Alliance Medical Group
Australian Nuclear Science And Technology Organisation
Aytu Bioscience Inc.
Bayer Pharma Ag
Blue Earth Diagnostics Ltd.
Board Of Radiation And Isotope Technology
Bracco Diagnostic Inc.
BTG International Ltd.
C. R. Bard Inc. (Becton Dickinson)
Cardinal Health Inc.
Clarity Pharmaceuticals
Coqu Radiopharmaceuticals Corp.
Eckert & Ziegler Bebig
Elekta
Eli Lilly And Co.
Fujifilm Ri Pharma Co. Ltd.
GE Healthcare
IBA Molecular (Now Curium)
Isoray Medical Inc.
Iso-Tex Diagnostics Inc.
Jubilant Draximage Inc.
Lantheus Medical Imaging Inc.
Nanothea
National Centre For Nuclear Research Polatom
National Institute For Radioelements (Ire)
Navidea Biopharmaceuticals Inc.
Nordion Inc.
NTP Radioisotopes Soc Ltd.
Pharmalucence Inc.
PMB Alcen
Siemens Healthcare Gmbh (Now Siemens Healthineers)
Spectrum Pharmaceuticals Inc.
Triad Isotopes Inc.
Varian Medical Systems
Zevacor Molecular

For more information about this report visit https://www.researchandmarkets.com/r/qh43hv

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets